ALTering Cancer by Triggering Telomere Replication Stress through the Stabilization of Promoter G-Quadruplex in SMARCAL1
ACS Chemical Biology · 2024
DOI: 10.1021/acschembio.4c00285 ↗At a glance
Leserbrief in ACS Chemical Biology, 2024. Written by Suman Panda and 5 co-authors. Institution: Department of Biophysics, Bose Institute, EN 80, Sector V, Bidhan Nagar, Kolkata 700091 West Bengal, India. Major MEDLINE topics: G-Quadruplexes, Telomere, DNA Helicases, Promoter Regions, Genetic. Cited 2 times so far (Crossref); 45 references. Funded by: University Grants Commission, Science and Engineering Research Board, Bose Institute.
Abstract (original language)
Most of the human cancers are dependent on telomerase to extend the telomeres. But ∼10% of all cancers use a telomerase-independent, homologous recombination mediated pathway called alternative lengthening of telomeres (ALT). Due to the poor prognosis, ALT status is not being considered yet in the diagnosis of cancer. No such specific treatment is available to date for ALT positive cancers. ALT positive cancers are dependent on replication stress to deploy DNA repair pathways to the telomeres to execute homologous recombination mediated telomere extension. SMARCAL1 (SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily A-like 1) is associated with the ALT telomeres to resolve replication stress thus providing telomere stability. Thus, the dependency on replication stress regulatory factors like SMARCAL1 made it a suitable therapeutic target for the treatment of ALT positive cancers. In this study, we found a significant downregulation of SMARCAL1 expression by stabilizing the G-quadruplex (G4) motif found in the promoter of SMARCAL1 by potent G4 stabilizers, like TMPyP4 and BRACO-19. SMARCAL1 downregulation led toward the increased localization of PML (promyelocytic leukemia) bodies in ALT telomeres and triggered the formation of APBs (ALT-associated promyelocytic leukemia bodies) in ALT positive cell lines, increasing telomere replication stress and DNA damage at a genomic level. Induction of replication stress and hyper-recombinogenic phenotype in ALT positive cells mediated by G4 stabilizing molecules already highlighted their possible application as a new therapeutic window to target ALT positive tumors. In accordance with this, our study will also provide a valuable insight toward the development of G4-based ALT therapeutics targeting SMARCAL1.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Biophysics, Bose Institute, EN 80, Sector V, Bidhan Nagar, Kolkata 700091 West Bengal, India.
- Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, New York 10065, United States of America.
- Division of Molecular Medicine, Centenary Campus, Bose Institute, P-1/12 C.I.T. Scheme VII-M, Kolkata 700054, India.
ORCID profiles: Subhrangsu Chatterjee
Funding
- University Grants Commission
- Science and Engineering Research Board
- Bose Institute
Cite
APA
Panda, S., Roychowdhury, T., Dutta, A., Chakraborty, S., Das, T., & Chatterjee, S. (2024). ALTering Cancer by Triggering Telomere Replication Stress through the Stabilization of Promoter G-Quadruplex in SMARCAL1. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00285
Vancouver
Panda S, Roychowdhury T, Dutta A, Chakraborty S, Das T, Chatterjee S. ALTering Cancer by Triggering Telomere Replication Stress through the Stabilization of Promoter G-Quadruplex in SMARCAL1. ACS Chemical Biology. 2024. doi:10.1021/acschembio.4c00285
BibTeX
@article{Panda2024,
author = {Panda, Suman and Roychowdhury, Tanaya and Dutta, Anindya and Chakraborty, Sourio and Das, Tanya and Chatterjee, Subhrangsu},
title = {ALTering Cancer by Triggering Telomere Replication Stress through the Stabilization of Promoter G-Quadruplex in SMARCAL1},
journal = {ACS Chemical Biology},
year = {2024},
doi = {10.1021/acschembio.4c00285}
}
EUVIMED